Child health nursing Important topics according to inc for exam point of view
INC India nursing exam important topics child health nursing pediatric nursing
https://www.indiannursingcouncil.org/uploads/pdf/17296837541…
INC BSc nursing exam child health nursing important topics growth development IMNCI immunization
https://www.scribd.com/document/476738288/Child-Health-Nsg-I…
| Rank | Topic |
|---|---|
| 1 | Growth & Development milestones |
| 2 | National Immunization Schedule |
| 3 | Nursing management of preterm/LBW baby |
| 4 | IMNCI - assessment and classification |
| 5 | Protein Energy Malnutrition (Kwashiorkor & Marasmus) |
| 6 | Nephrotic Syndrome |
| 7 | Tetralogy of Fallot (TOF) |
| 8 | Meningitis - nursing management |
| 9 | Thalassemia |
| 10 | Neonatal jaundice / Hyperbilirubinemia |
Explain each one of them in extreme details according to 50 marks
There are 16 units with dozens of topics — explaining ALL of them at 50-mark depth would be extremely long (500+ pages). Which would you like? · What format do you want the output in?
Which topic do you want to start with?
| Factor | Effect |
|---|---|
| Genetic inheritance | Determines height, weight, mental capacity, and personality |
| Age | Growth rate is maximum during fetal life, first year, and puberty |
| Sex | Girls have growth spurt at 10-11 years; boys at 12-13 years |
| Birth weight | Low birth weight affects subsequent development |
| Hormones | Growth hormone, thyroid hormone, insulin, sex hormones |
| Factor | Effect |
|---|---|
| Nutrition | Most important modifiable factor; malnutrition causes growth retardation |
| Infections | Repeated infections (diarrhea, measles) slow growth; maternal infections (rubella, syphilis) affect fetal growth |
| Parasitic infestations | Roundworms compete for nutrients and hamper growth |
| Physical surroundings | Sunshine, ventilation, good housing promote growth |
| Psychological factors | Love, secure attachment, parent-child relationship promote emotional and intellectual development |
| Economic factors | Higher socioeconomic status = better nutrition and living conditions = better growth |
| Education of parents | Educated parents provide better child-rearing practices |
| Birth order and spacing | Closely spaced births with poor spacing can impair individual child's nutrition |
| Age | Weekly Gain |
|---|---|
| 0-3 months | 200 g/week |
| 4-6 months | 150 g/week |
| 7-9 months | 100 g/week |
| 10-12 months | 50-75 g/week |
| 1-2 years | 2.5 kg/year |
| 3-5 years | 2.0 kg/year |
| Age | Gross Motor | Fine Motor / Adaptive | Language | Personal-Social |
|---|---|---|---|---|
| Newborn | Flexed posture, turns head to side | Grasp reflex present | Cries | Regards face |
| 6-8 weeks | Raises head briefly prone | - | - | Social smile (most imp!) |
| 3 months | Holds head erect; raises chest | Hands open at rest | Coos, vocalizes | Recognizes mother |
| 4-5 months | Rolls over (prone to supine) | Reaches for objects | Laughs aloud | Recognizes mother clearly |
| 6 months | Sits with support; rolls both ways | Transfers objects hand to hand | Babbles (ma-ma, da-da - non-specific) | Enjoys peek-a-boo/hide and seek |
| 9 months | Sits without support; crawls | Pincer grasp (crude) | "mama/dada" non-specific; understands "no" | Stranger anxiety (suspicious of strangers) |
| 10-11 months | Stands with support; cruises | Neat pincer grasp | First words with meaning | Waves bye-bye |
| 12 months | Walks with one hand held; stands alone | Releases objects voluntarily | 1-2 meaningful words | Comes when called |
| 15 months | Walks independently (wide base) | Tower of 2 cubes | 4-6 words | Uses cup/spoon |
| 18 months | Runs (narrow base beginning); walks up stairs with support | Tower of 3-4 cubes; scribbles | 8-10 words; points to body parts | Feeds self with spoon; dry by day |
| 2 years | Runs well; up/down stairs both feet | Tower of 6-7 cubes; copies vertical line | 2-3 word sentences; 50 words | Parallel play; dry by day |
| 3 years | Rides tricycle; jumps | Tower of 9 cubes; copies circle | Full sentences; asks questions | Dresses/undresses with help; associative play |
| 4 years | Hops on one foot; skips | Copies cross (+) | Tells stories | Cooperative play; follows rules |
| 5 years | Skips alternating feet | Copies triangle | 2000 words vocabulary; names 4 colors | Dresses independently |
| 6 years | Rides bicycle | Copies diamond | Reads; writes name | Plays competitive games |
| Reflex | How to Elicit | Response | Disappears By |
|---|---|---|---|
| Moro (Startle) | Sudden movement/noise | Arms abduct, extend then flex (embracing) | 3-4 months |
| Rooting | Stroke corner of mouth | Turns head toward stimulus | 3-4 months |
| Sucking | Touch lips/palate | Sucking movements | 4 months (awake); persists during sleep |
| Palmar grasp | Place finger in palm | Fingers flex and grip | 3-4 months |
| Plantar grasp | Press sole below toes | Toes flex and curl | 9-12 months |
| Babinski | Stroke lateral sole | Dorsiflexion of big toe, fanning of others | 12-18 months |
| Stepping/Walking | Hold upright, touch sole to surface | Stepping movements | 2 months |
| Tonic Neck Reflex (TNR) | Turn head to one side | Same side arm extends, opposite arm flexes (fencing) | 4-6 months |
| Parachute reflex | Hold prone, lower toward surface | Arms extend outward | Appears at 8-9 months; persists lifelong |
| Stage | Age | Focus | Fixation leads to |
|---|---|---|---|
| Oral | 0-1 year | Mouth (feeding, sucking) | Dependency, smoking |
| Anal | 1-3 years | Anus (bowel control) | Rigidity or messiness |
| Phallic | 3-6 years | Genitals (Oedipus/Electra complex) | Guilt, authority issues |
| Latency | 6-12 years | School, peers | - |
| Genital | 12+ years | Sexual maturity | - |
| Stage | Age | Crisis | Healthy Resolution |
|---|---|---|---|
| Infancy | 0-2 years | Trust vs. Mistrust | Consistent nurturing builds trust |
| Toddler | 2-4 years | Autonomy vs. Shame & Doubt | Allow safe exploration |
| Preschool | 5-7 years | Initiative vs. Guilt | Set limits for protection, not condemnation |
| School age | 8-12 years | Industry vs. Inferiority | Encourage achievement and competence |
| Adolescence | 13-17 years | Identity vs. Role Confusion | Support career goals and independence |
| Stage | Age | Key Feature | Characteristics |
|---|---|---|---|
| Sensorimotor | 0-2 years | Object permanence (8-9 months) | Learning through senses and movement |
| Pre-operational | 2-7 years | Egocentrism, magical thinking | Cannot understand conservation; animism |
| Concrete operational | 7-11 years | Logical reasoning about concrete things | Conservation, classification, seriation |
| Formal operational | 12+ years | Abstract reasoning | Hypothetical thinking |
| Level | Age | Stage | Description |
|---|---|---|---|
| Pre-conventional | 2-7 years | Punishment & Obedience; Self-interest | Rules followed to avoid punishment |
| Conventional | 7-11 years | Good boy/girl; Law & Order | Rules followed to please others |
| Post-conventional | 12+ years | Social contract; Universal principles | Rules based on ethical principles |
| Teeth | Eruption Age | Shedding Age |
|---|---|---|
| Lower central incisors | 6-8 months | 6-7 years |
| Upper central incisors | 8-10 months | 7-8 years |
| Lateral incisors | 10-12 months | 7-9 years |
| First molars | 12-16 months | 9-11 years |
| Canines | 16-20 months | 10-12 years |
| Second molars | 20-30 months | 11-13 years |
| Classification | Indicator | Meaning |
|---|---|---|
| Underweight | Weight-for-age < -2 SD | Current or past malnutrition |
| Stunting | Height-for-age < -2 SD | Chronic/past malnutrition |
| Wasting | Weight-for-height < -2 SD | Acute/current malnutrition |
| MUAC < 12.5 cm | Mid-upper arm circumference | Severe acute malnutrition |
| Type | Age | Description |
|---|---|---|
| Solitary play | < 2 years | Plays alone without regard for others |
| Parallel play | 2-3 years | Plays alongside others, not with them |
| Associative play | 3-4 years | Interacts with others but no organized goal |
| Cooperative play | 4+ years | Organized, goal-directed group play |
| Onlooker play | Any | Observes others without participating |
| Age | Red Flag |
|---|---|
| 2 months | No social smile |
| 4 months | No head control; hands still fisted |
| 6 months | Cannot sit with support; no babbling |
| 9 months | No stranger anxiety; no pincer grasp developing |
| 12 months | No single meaningful word; not standing with support |
| 18 months | Not walking independently; fewer than 5-6 words |
| 2 years | No two-word phrases; not running |
| 3 years | Cannot climb stairs; speech not understood by strangers |
| Any age | Loss of previously acquired milestones (most serious) |
Exam tip: For 50-mark answers, always include: definition, principles, factors, physical parameters with formulas, milestone table (4 streams), primitive reflexes, developmental theories (Erikson + Piaget are most important), DDST, growth chart, play types, nursing implications, and red flags. Each section alone can carry 5-8 marks.
Next
India national immunization schedule 2024 2025 UIP vaccines list updated
| Year | Milestone |
|---|---|
| 1978 | Expanded Programme of Immunization (EPI) launched - BCG, DPT, OPV, Typhoid (urban areas) |
| 1983 | TT vaccine for pregnant women introduced |
| 1985 | Universal Immunization Programme (UIP) launched |
| 1990 | UIP expanded nationally; Vitamin A supplementation added |
| 1992 | Integrated with Child Survival and Safe Motherhood (CSSM) |
| 1997 | Reproductive and Child Health (RCH) programme |
| 2005 | National Rural Health Mission (NRHM) launched |
| 2006 | Hepatitis B vaccine included in NIS |
| 2011 | Pentavalent vaccine replaced DPT + Hep B + Hib separately |
| 2014 | Mission Indradhanush launched |
| 2016 | IPV (Inactivated Polio Vaccine), Rotavirus vaccine, Adult JE vaccine added |
| 2017 | MR (Measles-Rubella) vaccine replaced Measles vaccine |
| 2017 | PCV (Pneumococcal Conjugate Vaccine) added (select states) |
| Vaccine | When to Give | Dose | Route | Site |
|---|---|---|---|---|
| TT/Td - 1 | Early in pregnancy | 0.5 ml | Intramuscular | Upper arm |
| TT/Td - 2 | 4 weeks after TT-1 | 0.5 ml | Intramuscular | Upper arm |
| TT/Td - Booster | If received 2 TT doses in a pregnancy within last 3 years | 0.5 ml | Intramuscular | Upper arm |
| Vaccine | When to Give | Dose | Route | Site |
|---|---|---|---|---|
| BCG | At birth (or as early as possible till 1 year) | 0.1 ml (0.05 ml until 1 month) | Intradermal | Left upper arm |
| Hepatitis B (Birth dose) | At birth, within 24 hours | 0.5 ml | Intramuscular | Antero-lateral mid-thigh |
| OPV-0 | At birth, within first 15 days | 2 drops | Oral | Oral |
| OPV 1, 2, 3 | 6 weeks, 10 weeks, 14 weeks | 2 drops | Oral | Oral |
| Pentavalent 1, 2, 3 | 6 weeks, 10 weeks, 14 weeks | 0.5 ml | Intramuscular | Antero-lateral mid-thigh |
| PCV (Pneumococcal Conjugate) | 6 weeks & 14 weeks (primary); booster at 9-12 months | 0.5 ml | Intramuscular | Antero-lateral mid-thigh |
| Rotavirus (RVV) | 6 weeks, 10 weeks, 14 weeks | 3 drops | Oral | Oral |
| IPV (Inactivated Polio) | 6 weeks and 14 weeks (fractional doses) | 0.1 ml | Intradermal | Right upper arm |
| MR 1st dose | 9-12 completed months | 0.5 ml | Subcutaneous | Right upper arm |
| JE-1 (endemic districts) | 9-12 completed months | 0.5 ml | Subcutaneous | Left upper arm |
| Vitamin A (1st dose) | At 9 completed months (with MR vaccine) | 1 ml (1 lakh IU) | Oral | Oral |
| Vaccine | When to Give | Dose | Route | Site |
|---|---|---|---|---|
| MR 2nd dose | 16-24 months | 0.5 ml | Subcutaneous | Right upper arm |
| DPT Booster-1 | 16-24 months | 0.5 ml | Intramuscular | Antero-lateral mid-thigh |
| OPV Booster | 16-24 months | 2 drops | Oral | Oral |
| JE-2 (endemic districts) | 16-24 months | 0.5 ml | Subcutaneous | Left upper arm |
| Vitamin A (2nd to 9th dose) | 16 months, then every 6 months till 5 years | 2 ml (2 lakh IU) | Oral | Oral |
| DPT Booster-2 | 5-6 years | 0.5 ml | Intramuscular | Upper arm |
| OPV (5 years) | 5 years | 2 drops | Oral | Oral |
| Vaccine | When to Give | Dose | Route | Site |
|---|---|---|---|---|
| TT | 10 years and 16 years | 0.5 ml | Intramuscular | Upper arm |
| Type | Examples | Key Feature |
|---|---|---|
| Live attenuated | BCG, OPV, MR, RVV, Yellow Fever | Weakened pathogen; stronger immunity; contraindicated in immunocompromised |
| Killed/Inactivated | IPV, Hepatitis A, Influenza, Pertussis (whole cell) | Heat-killed; safer; needs boosters |
| Toxoid | TT, Diphtheria | Inactivated toxin; protects against toxin action |
| Subunit/Recombinant | Hepatitis B, HPV, PCV | Contains specific antigens; very safe |
| Conjugate | Hib, PCV, Meningococcal | Polysaccharide linked to protein carrier; works in infants < 2 years |
| Vaccine | Storage Temperature |
|---|---|
| OPV | -15°C to -25°C (frozen) |
| BCG, MR, MMR, Varicella | +2°C to +8°C |
| DPT, TT, DT, Hepatitis B, Pentavalent, IPV, PCV | +2°C to +8°C (must NOT be frozen - freeze-sensitive) |
| Level | Equipment | Temperature |
|---|---|---|
| National/State | Walk-In Freezer (WIF) | -15°C to -25°C |
| National/State/Regional | Walk-In Cooler (WIC) | +2°C to +8°C |
| District/PHC | Deep Freezer (DF) | -15°C to -25°C (for OPV) |
| PHC/Subcentre | Ice-Lined Refrigerator (ILR) | +2°C to +8°C |
| Field/session site | Vaccine carrier with ice packs | +2°C to +8°C |
| Transport | Cold boxes | +2°C to +8°C |
| Type | Description | Examples |
|---|---|---|
| Vaccine product-related | Due to inherent property of vaccine | BCG lymphadenitis, Rotavirus intussusception |
| Vaccine quality defect-related | Due to manufacturing defect | Contaminated vaccine |
| Immunization error-related | Due to improper preparation/handling | Wrong dose, wrong route, contaminated syringe |
| Immunization anxiety-related | Due to anxiety, fear of injection | Vasovagal syncope |
| Coincidental | Unrelated to vaccine - temporal association only | Fever due to unrelated infection |
| Vaccine | Common AEFI | Serious AEFI |
|---|---|---|
| BCG | Local induration, ulcer, scar | BCG-itis, disseminated BCG disease |
| DPT/Pentavalent | Local pain, swelling, fever | Febrile convulsions, hypotonic-hyporesponsive episode (HHE) |
| OPV | None usually | Vaccine-associated paralytic polio (VAPP) |
| MR/Measles | Mild rash, fever after 5-10 days | Anaphylaxis (rare) |
| Hepatitis B | Local pain | Anaphylaxis (very rare) |
| Indicator | Definition |
|---|---|
| Full immunization | Child receives BCG + 3 OPV + 3 Pentavalent + MR before 1 year |
| Partial immunization | Received some but not all vaccines |
| Unimmunized | No vaccine received |
| DPT3 coverage | Percentage receiving 3 doses of DPT - best indicator of programme performance |
| IMR | Number of infant deaths per 1000 live births |
Exam tip for 50 marks: Always include Introduction + Historical milestones + Full NIS table (most marks here) + Cold chain with equipment and temperatures + Individual vaccine details (BCG scar, OPV vs IPV, pentavalent components) + AEFI classification and management + Nursing responsibilities. These sections together will easily cover a full 50-mark answer.
Next
| Category | Birth Weight |
|---|---|
| Normal birth weight | ≥ 2500 g |
| Low Birth Weight (LBW) | < 2500 g |
| Very Low Birth Weight (VLBW) | < 1500 g |
| Extremely Low Birth Weight (ELBW) | < 1000 g |
| Category | Gestational Age |
|---|---|
| Late preterm | 34 0/7 to 36 6/7 weeks |
| Moderate preterm | 32 0/7 to 33 6/7 weeks |
| Very preterm (VP) | 28 0/7 to 31 6/7 weeks |
| Extremely preterm (EP) | < 28 0/7 weeks |
| Term | 37 to 41 6/7 weeks |
| Post-term | ≥ 42 weeks |
| Type | Definition |
|---|---|
| Appropriate for Gestational Age (AGA) | Birth weight between 10th-90th percentile |
| Small for Gestational Age (SGA) | Birth weight < 10th percentile (Intrauterine Growth Restriction - IUGR) |
| Large for Gestational Age (LGA) | Birth weight > 90th percentile |
| System | Characteristics |
|---|---|
| General appearance | Small, thin, scrawny appearance; head appears large relative to body |
| Skin | Thin, translucent, red/pink; veins visible; abundant lanugo hair; little subcutaneous fat; wrinkled |
| Skull | Soft, wide sutures and fontanelles; skull bones soft and pliable |
| Ears | Soft, pliable cartilage; ears fold easily and slowly return |
| Eyes | Fused eyelids (< 26 weeks); poorly reactive pupils |
| Breast tissue | No breast nodule (< 34 weeks) |
| Genitalia | Male: undescended testes, scrotum smooth; Female: prominent labia minora, clitoris |
| Plantar creases | Absent or only in anterior 1/3 (< 36 weeks); full foot creases at term |
| Muscle tone | Hypotonic; frog-leg posture |
| Reflexes | Weak or absent sucking and swallowing reflexes (mature at 32-34 weeks) |
| Nails | Soft, not reaching fingertips |
| Parameter | Score 0 | Score 1 | Score 2 |
|---|---|---|---|
| Appearance (Color) | Blue/pale all over | Blue extremities, pink body | Pink all over |
| Pulse (Heart Rate) | Absent | < 100 bpm | ≥ 100 bpm |
| Grimace (Reflex irritability) | No response | Grimace/weak cry | Cough, sneeze, cry |
| Activity (Muscle tone) | Limp | Some flexion | Active flexion |
| Respiration | Absent | Weak, irregular | Strong cry |
| Mechanism | Prevention |
|---|---|
| Radiation (to cold surfaces) | Keep away from cold walls/windows |
| Convection (to air currents) | Avoid drafts; use warm room |
| Conduction (to cold surfaces in contact) | Warm mattress, warm linen |
| Evaporation (from wet skin) | Dry immediately; warm humidified incubator |
| System | Complication |
|---|---|
| Neurological | Cerebral palsy, cognitive delay, learning disability, ADHD, autism |
| Pulmonary | Chronic Lung Disease (CLD) / Bronchopulmonary Dysplasia (BPD) |
| Visual | Retinopathy of prematurity (ROP), blindness |
| Hearing | Sensorineural hearing loss |
| Growth | Failure to thrive, short stature |
| Metabolic | Increased risk of diabetes, hypertension, cardiovascular disease in adult life (Barker hypothesis) |
| Nursing Diagnosis | Goal | Interventions |
|---|---|---|
| Ineffective thermoregulation r/t immature heat production | Maintain temp 36.5-37.5°C | Radiant warmer/incubator, KMC, warm clothing, monitor temperature |
| Ineffective breathing pattern r/t immature lungs | Maintain SpO₂ 91-95% | CPAP, position, monitor RR and SpO₂ |
| Imbalanced nutrition: less than body requirements r/t weak suck | Adequate weight gain 15-20 g/kg/day | Tube feeding, EBM, KMC for breastfeeding support |
| Risk for infection r/t immature immune system | No signs of sepsis | Hand hygiene, aseptic technique, minimal handling |
| Risk for hypoglycemia r/t low glycogen stores | Blood glucose 45-120 mg/dL | Early feeds, blood glucose monitoring, IV dextrose |
| Anxiety of parents r/t premature birth | Parents verbalize understanding | Counseling, teaching, KMC involvement |
Exam tip for 50 marks: Always include: definitions with weight/gestational age classifications + causes + physical characteristics (Ballard score) + problems table (all systems) + Apgar scoring table + detailed nursing management (Thermoregulation is the MOST marks-bearing section) + KMC components and benefits + NRP steps + nursing care plan + discharge criteria. The examiner expects you to write as if you are managing the baby at the bedside.
Next
| Component | Description |
|---|---|
| 1. Improving case management skills of health workers | Training ANMs, nurses, medical officers to use standard case management guidelines |
| 2. Improving overall health system | Ensuring drug availability, functioning referral systems, and supportive supervision |
| 3. Improving family and community practices | Educating families on home care, danger signs, feeding, immunization |
ASSESS (history + examination using standard guidelines)
↓
CLASSIFY (color-coded triage: Red / Yellow / Green)
↓
TREAT (according to classification)
↓
COUNSEL (follow-up, home care, feeding, immunization)
| Age | Fast Breathing (Tachypnea) |
|---|---|
| < 2 months | ≥ 60 breaths/min |
| 2-12 months | ≥ 50 breaths/min |
| 12 months - 5 years | ≥ 40 breaths/min |
| Classification | Signs | Action | Color |
|---|---|---|---|
| Very Severe Disease / Severe Pneumonia | Any general danger sign OR chest indrawing OR stridor in calm child | URGENT referral; pre-refer: first dose cotrimoxazole/amoxicillin; paracetamol if fever | RED |
| Pneumonia | Fast breathing (no chest indrawing, no danger signs) | Give amoxicillin for 5 days; paracetamol for fever; soothe throat; follow up in 2 days | YELLOW |
| No Pneumonia: Cough or Cold | No fast breathing, no chest indrawing | Soothe throat with safe remedy; advise when to return; follow up in 5 days if not improving | GREEN |
| Classification | Signs | Treatment | Color |
|---|---|---|---|
| Severe Dehydration | 2 or more: lethargic/unconscious; sunken eyes; not able to drink; skin pinch goes back very slowly (≥2 seconds) | URGENT referral; IV fluids (Ringer's Lactate); Plan C | RED |
| Some Dehydration | 2 or more: restless/irritable; sunken eyes; drinks eagerly/thirsty; skin pinch goes back slowly | ORS in facility (75 ml/kg over 4 hours); Plan B; continue feeding | YELLOW |
| No Dehydration | Not enough signs for some/severe dehydration | Home ORS; Plan A; continue feeding | GREEN |
| Classification | Signs | Treatment | Color |
|---|---|---|---|
| Very Severe Febrile Disease / Severe Malaria | Any general danger sign OR stiff neck OR petechiae | URGENT referral; quinine/artesunate; paracetamol | RED |
| Malaria | Fever only (no stiff neck, no danger signs) | Antimalarial; paracetamol; return if not improving | YELLOW |
| Fever - Malaria Unlikely | Fever < 7 days; no clear cause | Paracetamol; treat underlying cause | GREEN |
| Classification | Signs | Treatment | Color |
|---|---|---|---|
| Severe complicated measles | General danger sign OR cloudy cornea OR deep/extensive mouth ulcers | URGENT referral; Vitamin A; antibiotics | RED |
| Measles with eye/mouth complications | Pus from eyes OR mouth ulcers | Vitamin A; treat eyes; gentian violet for mouth | YELLOW |
| Measles | Rash + fever + cough/runny nose/red eyes | Vitamin A; follow up | GREEN |
| Classification | Signs | Treatment | Color |
|---|---|---|---|
| Mastoiditis | Tender swelling behind ear | URGENT referral; first dose antibiotics | RED |
| Acute ear infection | Ear pain or pus < 14 days | Amoxicillin for 5 days; dry ear; paracetamol | YELLOW |
| Chronic ear infection | Ear discharge ≥ 14 days | Dry ear 3 times daily; no antibiotics unless signs worsen | YELLOW |
| No ear infection | No ear pain, no discharge | - | GREEN |
| Classification | Signs | Treatment | Color |
|---|---|---|---|
| Severe malnutrition / Severe anaemia | Severe visible wasting OR bilateral pitting oedema OR severe palmar pallor | URGENT referral | RED |
| Anaemia or Very Low Weight | Some palmar pallor OR very low weight-for-age | Iron for 14 days; mebendazole; feeding advice; follow up | YELLOW |
| No anaemia; Not very low weight | No palmar pallor; weight in acceptable range | Advise on feeding; praise | GREEN |
| Classification | Signs | Treatment |
|---|---|---|
| Possible Serious Bacterial Infection | Any of the above signs | URGENT referral; pre-refer: Ampicillin + Gentamicin IM |
| Local bacterial infection | Pus from eye OR umbilical redness NOT extending to skin OR < 10 skin pustules | Treat at home; antibiotics; return in 2 days |
| No infection | None of the above | Home care; counsel on feeding |
| Classification | Signs | Treatment |
|---|---|---|
| Severe jaundice | Yellow palms and soles at any age OR jaundice appearing in first 24 hours | URGENT referral; keep warm during transport |
| Jaundice | Jaundice appearing after 24 hours with yellow eyes/skin but NOT palms/soles | Advise to return in 1 day; advise on breastfeeding |
| No jaundice | No yellow coloration | Normal care |
| Age | Breastfed | Non-breastfed |
|---|---|---|
| 6-8 months | 2-3 times | 4-5 times |
| 9-23 months | 3-4 times | 4-5 times |
| Color | Meaning | Action |
|---|---|---|
| RED | Urgent - needs immediate referral | Urgent pre-treatment + refer to hospital |
| YELLOW | Moderate - needs specific treatment | Treat at home with oral medication; follow-up in 2-5 days |
| GREEN | Mild / No illness | Home care; advise mother; no medication needed |
| Illness | Follow-up In |
|---|---|
| Pneumonia (after antibiotic started) | 2 days |
| Diarrhoea with some dehydration (after Plan B) | 5 days |
| Dysentery | 2 days |
| Fever / Malaria (if not improving) | 2 days |
| Measles with complications | 2 days |
| Ear infection (acute) | 5 days |
| Malnutrition / very low weight | 30 days |
| Persistent diarrhea (without dehydration) | 5 days |
| Feeding problem | 5 days |
Exam tip for 50 marks: Examiners expect: Introduction with the 5 killer diseases + Objectives + 3 components + IMNCI vs IMCI differences + Full assessment flow (danger signs, then each condition separately) + Color-coded classification tables for each illness + ORS Plans A/B/C with ORS composition + Feeding counseling + Nursing responsibilities + Follow-up schedule. The classification tables carry the maximum marks.
Next
| Term | Definition |
|---|---|
| Undernutrition | Deficiency of energy, protein, or micronutrients resulting from inadequate intake, poor absorption, or increased requirements |
| Malnutrition | Broader term covering both undernutrition and overnutrition |
| Severe Acute Malnutrition (SAM) | Weight-for-height < -3 SD OR MUAC < 115 mm OR bilateral pitting oedema |
| Moderate Acute Malnutrition (MAM) | Weight-for-height -2 to -3 SD OR MUAC 115-124 mm |
| Marasmus | Severe calorie AND protein deficiency; NO oedema; extreme wasting |
| Kwashiorkor | Predominantly protein deficiency with adequate/excess carbohydrate; WITH oedema |
| System | Features |
|---|---|
| General | Extreme wasting; "old man" or "monkey face" appearance; weight < 60% of expected |
| Face | Drawn, wizened, sunken cheeks (buccal fat pad lost); loose skin around mouth |
| Eyes | Sunken eyes; alert and hungry-looking (unlike kwashiorkor child who is apathetic) |
| Skin | Loose, baggy skin hanging in folds especially over buttocks and thighs ("baggy pants" sign); dry, wrinkled; no oedema |
| Subcutaneous fat | Severely depleted or absent |
| Muscles | Severely wasted; prominent ribs, scapulae, iliac crests |
| Hair | May be sparse but usually retains colour |
| Oedema | ABSENT |
| Liver | Usually normal size |
| Mood | Irritable, alert, hungry, crying |
| Weight | < 60% of expected (Grade III-IV Gomez) |
| System | Features |
|---|---|
| General | Weight 60-80% of expected; oedema may mask wasting |
| Face | "Moon face" due to oedema |
| Skin | Classic "flaky paint" or "enamel paint" dermatitis - areas of hyperpigmentation and desquamation; later erosions; peeling in sheets; depigmented patches |
| Hair | "Flag sign" (Bandeira sign) - alternating light and dark bands; hair becomes reddish-brown, silky, sparse, easily pluckable; flag sign pathognomonic of PEM |
| Oedema | PRESENT - bilateral pitting; starts in feet, progresses upward; may become generalized (anasarca) |
| Liver | Hepatomegaly with fatty infiltration (due to lack of apoprotein for VLDL); parotid glands may enlarge |
| Mood | Apathetic, miserable, irritable when touched, not hungry; sits/lies quietly |
| Eyes | Angular stomatitis; corneal changes if Vit A also deficient |
| GI tract | Diarrhea, vomiting; potbelly (distended abdomen) due to oedema and gas |
| Muscle | Wasting present but masked by oedema |
| Anaemia | Severe anaemia |
| Weight | 60-80% expected (body weight deceptively higher due to oedema) |
| Feature | Kwashiorkor | Marasmus |
|---|---|---|
| Cause | Protein deficiency (adequate calories) | Total calorie + protein deficiency |
| Age | 1-3 years (after weaning) | Infants < 1 year (also older) |
| Onset | Acute/subacute | Chronic, gradual |
| Body weight | 60-80% of expected | < 60% of expected |
| Oedema | Present (hallmark) | Absent |
| Wasting | Present but masked by oedema | Severe and obvious |
| Subcutaneous fat | Present | Absent/depleted |
| Skin | Flaky paint dermatitis; pigmentation changes | Dry, loose, baggy |
| Hair | Flag sign, reddish-brown, sparse, easily pluckable | May be sparse; colour may be retained |
| Face | Moon face (oedema) | Monkey/old man face (wasting) |
| Mood | Apathetic, miserable | Alert, hungry, irritable |
| Liver | Hepatomegaly (fatty) | Usually normal |
| Serum albumin | Very low (< 2.5 g/dL) | May be low but less severely |
| Serum proteins | Very low | Low |
| Anaemia | Severe | Moderate |
| Immunity | Severely impaired | Severely impaired |
| Potbelly | Present (oedema + ascites) | Present (gas/worm load) |
| Prognosis | Poorer | Better with treatment |
| Grade | Weight as % of expected (50th percentile) | Severity |
|---|---|---|
| Normal | 90-100% | Normal |
| Grade I | 75-89% | Mild |
| Grade II | 60-74% | Moderate |
| Grade III | < 60% | Severe (SAM) |
| Normal | Stunted (low ht-for-age) | |
|---|---|---|
| Not wasted (normal wt-for-ht) | Normal | Stunted (chronic past malnutrition) |
| Wasted (low wt-for-ht) | Acute malnutrition (wasting) | Wasted + Stunted (chronic + acute) |
| Grade | % of Standard | Oedema |
|---|---|---|
| Grade I | 71-80% | No |
| Grade II | 61-70% | No |
| Grade III | 50-60% | No |
| Grade IV | < 50% OR any oedema | ± |
| Criteria | Threshold |
|---|---|
| Weight-for-height | < -3 SD (< 70% of median) |
| MUAC (Mid-Upper Arm Circumference) | < 115 mm (< 11.5 cm) |
| Bilateral pitting oedema | Any grade = SAM |
| Investigation | Finding in PEM |
|---|---|
| Serum albumin | Very low in Kwashiorkor (< 2.5 g/dL; normal 3.5-5.5); less reduced in Marasmus |
| Total protein | Low |
| Haemoglobin | Low (anaemia) |
| Blood glucose | Low (hypoglycaemia - emergency) |
| Serum electrolytes | Low sodium, potassium, magnesium |
| Serum phosphorus | Low (risk of refeeding syndrome if replaced too fast) |
| Liver enzymes (SGOT, SGPT) | Elevated in Kwashiorkor (fatty liver) |
| Stool examination | Worm ova, occult blood |
| Urine | Specific gravity low; ketones possible |
| X-ray | Osteoporosis; delayed bone age |
| Skin test (tuberculin) | May be negative (anergy) due to immune suppression |
12 months: 200,000 IU
| Nursing Diagnosis | Goal |
|---|---|
| Imbalanced nutrition: less than body requirements r/t inadequate intake | Adequate weight gain 10-15 g/kg/day |
| Risk for fluid volume deficit/excess r/t oedema and refeeding | Balanced fluid status; oedema reduction |
| Risk for infection r/t immune suppression | No new infections; infection-free |
| Hypothermia r/t decreased subcutaneous fat | Temperature 36.5-37.5°C |
| Risk for hypoglycaemia r/t depleted glycogen stores | Blood glucose ≥ 54 mg/dL |
| Delayed growth and development r/t malnutrition | Age-appropriate development |
| Knowledge deficit (mother) r/t feeding practices | Mother demonstrates correct feeding |
Exam tip for 50 marks: Mandatory sections: Introduction + Definitions + Causes + Pathophysiology of both + Full clinical features table comparing Kwashiorkor and Marasmus (this table alone can fetch 15 marks) + Grading (Gomez + Waterlow) + Investigations + WHO 10-step management with F-75/F-100 details + Nursing care plan + Associated deficiencies (Vit A, Rickets) + Breastfeeding + Prevention (ICDS/NRC). Write the comparison table neatly as it is the highest-scoring single component.
Next
Massive Proteinuria → Hypoalbuminemia → Generalized Oedema + Hyperlipidemia/Lipiduria
| Type | Age Group | Frequency | Response to Steroids |
|---|---|---|---|
| Minimal Change Disease (MCD/MCNS) | 2-6 years | 80-85% of childhood NS | 90-95% respond |
| Focal Segmental Glomerulosclerosis (FSGS) | Older children/adolescents | ~10% | Poor |
| Membranous Nephropathy | Older children | Rare | Variable |
| Membranoproliferative GN (MPGN) | School age | Rare | Poor |
| Cause | Examples |
|---|---|
| Infections | Malaria (quartan), Hepatitis B, Hepatitis C, HIV, Syphilis |
| Systemic diseases | Lupus nephritis (SLE), Henoch-Schonlein Purpura (HSP), Diabetes mellitus |
| Drugs/Toxins | Gold, mercury, penicillamine, NSAIDs |
| Malignancies | Lymphomas, leukaemia |
| Hereditary | Congenital nephrotic syndrome (Finnish type) |
3.5 g/day in adults; > 40 mg/m²/hr in children
| Sign | Description |
|---|---|
| Periorbital oedema | Soft, pitting; most prominent in morning; reduces with activity |
| Pitting oedema | Bilateral lower limbs; ankles, feet; dependent |
| Ascites | Distended, tense, shifting dullness; fluid thrill |
| Scrotal/Vulval oedema | Gross oedema of genitalia |
| Pleural effusion | Dullness at bases; reduced breath sounds |
| Pallor | Dilutional + actual anaemia |
| Blood pressure | Usually normal or LOW (underfill) in MCD; may be elevated in secondary causes |
| Urine | Frothy, reduced output, may be dark |
| Malnutrition | Wasting under the oedema; low serum proteins |
| Xanthomas | Rarely, in long-standing hyperlipidaemia |
| Test | Finding |
|---|---|
| Urine dipstick | 3+ or 4+ protein (massive proteinuria) |
| 24-hour urine protein | > 3.5 g/day (adults); > 40 mg/m²/hr (children) |
| Urine microscopy | Oval fat bodies, lipid droplets, fatty casts; Maltese cross on polarized light; NO RBCs or RBC casts (unlike nephritic) |
| Urine protein:creatinine ratio | > 200 mg/mmol (> 2 mg/mg) = nephrotic range |
| Urine specific gravity | High (concentrated) |
| Test | Finding |
|---|---|
| Serum albumin | < 3 g/dL (< 2.5 g/dL = severe) |
| Total protein | Low |
| Serum cholesterol | Elevated (> 200 mg/dL) |
| Triglycerides | Elevated |
| LDL | Elevated |
| Blood urea nitrogen, Creatinine | Usually normal in MCD |
| Serum electrolytes | May show hyponatremia (dilutional) |
| Serum calcium | Low (loss of Vit D binding protein) |
| CBC | Anaemia; raised ESR |
| Serum complement (C3, C4) | Normal in MCD; low in MPGN, lupus |
| ANA, Anti-dsDNA | If lupus nephritis suspected |
| ASO titre | If post-streptococcal cause |
| Term | Definition |
|---|---|
| Remission | Urine protein nil or trace (< 4 mg/m²/hr) for 3 consecutive days |
| Relapse | Urine protein ≥ 3+ (> 40 mg/m²/hr) for 3 consecutive days after remission |
| Frequent relapser | ≥ 2 relapses in 6 months OR ≥ 4 relapses in 12 months |
| Steroid-dependent | Relapse during steroid tapering OR within 14 days of stopping |
| Steroid-resistant | No remission after 4 weeks of full-dose prednisolone |
| Drug | Use |
|---|---|
| Cyclophosphamide | Frequent relapsers; 2 mg/kg/day for 8-12 weeks; max 12 weeks (gonadal toxicity limit) |
| Levamisole | Immunomodulator; steroid-sparing; 2.5 mg/kg alternate days for 12 months |
| Cyclosporin A | Steroid-dependent/resistant; calcineurin inhibitor; nephrotoxic |
| Tacrolimus | Alternative to cyclosporin; less nephrotoxic |
| Mycophenolate mofetil (MMF) | Steroid-sparing in frequent relapsers |
| Rituximab | Anti-CD20; steroid-resistant MCD; biological agent |
| Feature | Nephrotic Syndrome | Nephritic Syndrome |
|---|---|---|
| Proteinuria | Massive (> 3.5 g/day) | Mild to moderate (subnephrotic) |
| Haematuria | Absent/minimal | Present (hallmark) |
| Oedema | Severe, generalised | Mild to moderate |
| Hypertension | Usually absent (MCD) | Present |
| Serum albumin | Very low | Normal/mildly low |
| Serum lipids | Elevated | Normal |
| Urine casts | Fatty casts, oval fat bodies | RBC casts (hallmark) |
| GFR / Creatinine | Usually normal | Reduced (azotaemia) |
| Urine output | Reduced | Oliguria |
| Complement (C3) | Normal (MCD) | Low (APSGN, SLE, MPGN) |
| Typical cause in children | MCD | APSGN (post-streptococcal) |
| Mechanism | Increased GBM permeability | Glomerular inflammation |
| Nursing Diagnosis | Related To | Goal |
|---|---|---|
| Fluid volume excess | Hypoalbuminemia, sodium retention | Reduction in oedema; maintain fluid balance |
| Risk for infection | Immunosuppression, protein loss | Prevent infection; early detection |
| Imbalanced nutrition: less than body requirements | Protein loss in urine, anorexia | Maintain adequate nutrition |
| Impaired skin integrity | Oedema, immobility | No skin breakdown |
| Risk for injury / thrombosis | Hypercoagulable state, immobility | No thrombotic events |
| Anxiety (child and parents) | Chronic illness, body image | Reduce anxiety; promote coping |
| Deficient knowledge | Disease process, medications | Parents demonstrate understanding of care |
Exam tip for 50 marks: Structure your answer as: Introduction + Definition (4 hallmarks with the chain) + Classification with causes + Pathophysiology (step-by-step chain) + Clinical features + Investigations table + Medical management (steroid protocol + response definitions are highest-yield) + Complications (peritonitis, thrombosis, hypovolaemia) + Nephrotic vs Nephritic comparison table + Full nursing care plan + Discharge teaching. The pathophysiology chain and the nephrotic vs nephritic table are the most frequently tested components.
Next
| Defect | Features |
|---|---|
| VSD (most common CHD overall) | Holosystolic murmur at LLSB; L-to-R shunt; pulmonary congestion |
| ASD | Fixed split S2; systolic ejection murmur; L-to-R shunt |
| PDA | Continuous "machinery" murmur; L-to-R shunt; bounding pulses |
| Pulmonary stenosis | Ejection murmur at LUSB; no shunt |
| Aortic stenosis | Ejection murmur at RUSB; radiates to neck |
| Coarctation of aorta | Hypertension in arms, low BP in legs; rib notching on X-ray |
| Defect | Features |
|---|---|
| TOF | Most common; boot-shaped heart; tet spells; squatting |
| TGA (Transposition of Great Arteries) | Egg-on-string CXR; parallel circulation; prostaglandin E1; Rashkind procedure |
| Tricuspid atresia | No tricuspid valve; requires shunt then Fontan procedure |
| Total anomalous pulmonary venous return (TAPVR) | All pulmonary veins drain to RA/systemic; snowman CXR (supracardiac type) |
| Truncus arteriosus | Single great vessel from both ventricles |
| Hypoplastic left heart syndrome (HLHS) | Tiny left side; most severe; requires Norwood/Fontan |
| Nursing Diagnosis | Interventions |
|---|---|
| Decreased cardiac output r/t structural defect | Monitor HR, BP, SpO₂ continuously; position in knee-chest during spells; administer prescribed medications |
| Impaired gas exchange r/t R-to-L shunt | Maintain SpO₂ as prescribed; administer supplemental O₂; position to maximize breathing |
| Activity intolerance r/t chronic hypoxia | Cluster care; schedule rest periods; avoid unnecessary stimulation |
| Imbalanced nutrition: less than body requirements r/t fatigue during feeding | Small, frequent feeds; fortified formula; nasogastric feeding if required; daily weight |
| Risk for thrombosis r/t polycythaemia | Maintain adequate hydration; avoid dehydration; iron supplementation; mobilize when possible |
| Risk for infection (SBE) r/t abnormal blood flow | Oral hygiene; prophylactic antibiotics before procedures; avoid unnecessary IV access |
| Anxiety (parents) r/t complex illness and impending surgery | Explain disease and plan of care; involve parents in care; provide emotional support |
Exam tip for 50 marks: Key sections the examiner expects: Introduction + 4 defects (PROV) with clear explanation + Pathophysiology (R-to-L shunt chain) + Clinical features (cyanosis, clubbing, tet spell mechanism, squatting mechanism - these two are highest scoring) + CXR findings (boot-shaped heart) + ECG + Echo + Management of tet spell step-by-step (this section alone can fetch 10-15 marks) + Surgical management (BTT shunt vs complete repair) + Full nursing care plan + Post-operative care. Diagrams of heart anatomy in the exam will earn bonus marks.
Next
| Type | Common Organisms | Features |
|---|---|---|
| Bacterial (Purulent) | Most dangerous | Acute onset, high mortality |
| Viral (Aseptic) | Enteroviruses (most common), HSV, Mumps | Usually self-limiting |
| Tuberculous (TB) | Mycobacterium tuberculosis | Subacute; very serious |
| Fungal | Cryptococcus neoformans | Mainly immunocompromised |
| Parasitic | Rare | Very rare in children |
| Age Group | Most Common Organisms |
|---|---|
| Neonates (0-28 days) | Group B Streptococcus (GBS), E. coli, Listeria monocytogenes |
| Infants 1-3 months | GBS, E. coli, Listeria, S. pneumoniae, N. meningitidis |
| 3 months - 6 years | Streptococcus pneumoniae (most common), Neisseria meningitidis |
| Older children/adolescents | Neisseria meningitidis (meningococcus) |
| Immunocompromised | Cryptococcus, Listeria, gram-negatives |
| Parameter | Normal | Bacterial Meningitis | Viral Meningitis | TB Meningitis |
|---|---|---|---|---|
| Appearance | Clear, colourless | Turbid/Cloudy/Purulent | Clear | Turbid/slightly cloudy |
| Opening pressure | 70-180 mm H₂O | Elevated (> 200 mm H₂O) | Normal/mildly elevated | Elevated |
| WBC (cells/mm³) | < 10 | > 100; often 1000-10,000 | 10-100 | 10-400 |
| Cell type | Mononuclear | PMN (neutrophils) 80-90% | Mononuclear (lymphocytes) | Lymphocytes |
| Protein (mg/dL) | < 60 | > 100 (often 200-500) | 60-100 | 100-500 |
| Glucose (mg/dL) | 40-80 | < 40 (LOW) | 40-80 (Normal) | Low (< 45) |
| CSF:Blood glucose | > 0.6 | < 0.4 | > 0.6 | < 0.5 |
| Gram stain | Negative | Positive in 60-90% | Negative | Negative (AFB smear) |
| Culture | Sterile | Positive | Negative | Positive (LJ medium; 6-8 weeks) |
| Age | First-line empirical | Alternative |
|---|---|---|
| Neonates 0-4 weeks | Ampicillin + Gentamicin (or cefotaxime) | Covers GBS, E. coli, Listeria |
| Infants 1-3 months | Ampicillin + Cefotaxime | Covers neonatal + childhood pathogens |
| Children > 3 months | Ceftriaxone (100 mg/kg/day ÷ 1-2 doses) OR Cefotaxime | Covers Pneumococcus + Meningococcus |
| Penicillin-resistant Pneumococcus | Ceftriaxone + Vancomycin | |
| TB meningitis | HRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol) for 2 months; then HR for 10 months |
| Complication | Description |
|---|---|
| Cerebral herniation | Fatal; from raised ICP unchecked |
| Septic shock | Especially meningococcaemia; DIC |
| Disseminated Intravascular Coagulation (DIC) | From endotoxaemia; petechiae, bleeding, organ failure |
| Waterhouse-Friderichsen syndrome | Bilateral adrenal haemorrhage; extreme cardiovascular collapse |
| Seizures | 15-40% cases; can lead to status epilepticus |
| SIADH | Hyponatraemia; worsens cerebral oedema |
| Subdural effusion | Fluid collection between dura and arachnoid; presents with persistent fever, bulging fontanelle, focal signs |
| Cerebral abscess | Extension of infection |
| Cranial nerve palsy | III, VI, VII most common; from inflammation or raised ICP |
| Complication | Frequency |
|---|---|
| Sensorineural hearing loss | Most common sequela; 15-25% of bacterial meningitis; worse in Pneumococcal and Hib |
| Intellectual disability | Cognitive impairment, learning difficulties |
| Cerebral palsy | Motor deficits from vascular infarction |
| Hydrocephalus | From CSF flow obstruction by inflammatory exudate |
| Epilepsy | Post-meningitic epilepsy |
| Behaviour problems | Attention deficit, hyperactivity |
| Visual impairment | Cortical blindness, optic nerve damage |
| Limb loss (meningococcaemia) | Skin/tissue necrosis from DIC and infarction |
| Nursing Diagnosis | Interventions |
|---|---|
| Risk for injury (brain herniation) r/t raised ICP | HOB 30°; neutral head position; avoid neck compression; monitor neuro signs hourly; osmotherapy as prescribed; report deteriorating GCS immediately |
| Hyperthermia r/t infection and inflammation | Monitor temperature 4-hourly; tepid sponging; antipyretics (paracetamol 15 mg/kg 4-6 hourly); remove excess clothing |
| Acute pain (headache) r/t meningeal irritation | Darkened quiet room (reduce photophobia/phonophobia); analgesics as prescribed; comfortable positioning; gentle, minimal handling |
| Risk for seizures r/t cerebral irritation | Padded side rails; airway management equipment at bedside; O₂ and suction ready; anticonvulsants as prescribed; document and time all seizures |
| Fluid volume imbalance r/t SIADH or dehydration | Strict intake-output; daily weight; fluid restriction if SIADH (2/3 maintenance); serum electrolytes monitoring; IV fluids as prescribed |
| Risk for infection spread r/t transmissible organism | Droplet precautions for meningococcal meningitis (for first 24 hours of antibiotics); single room; mask when within 1 metre; hand hygiene |
| Imbalanced nutrition r/t reduced consciousness, vomiting | Nasogastric tube feeding; aspiration precautions; advance diet as tolerated |
| Anxiety (family) r/t sudden serious illness | Update parents frequently; involve in care; explain procedures; emotional support; chaplain/counselor if needed |
| Type | Duration | Precaution |
|---|---|---|
| Meningococcal meningitis | First 24 hours of antibiotics | Droplet precautions (surgical mask; single room; gloves) |
| Bacterial meningitis (other) | Standard precautions | No special isolation required |
| TB meningitis | Until non-infectious | Airborne precautions (N95 mask; negative pressure room) |
| Feature | Bacterial | Viral (Aseptic) | TB |
|---|---|---|---|
| Onset | Acute (hours) | Acute (hours-days) | Subacute (days-weeks) |
| Fever | High grade | Moderate | Low grade |
| Severity | Severe, rapidly worsening | Mild-moderate | Progressive |
| CSF appearance | Turbid/purulent | Clear | Slightly cloudy |
| CSF cells | PMN > 100-10,000 | Lymphocytes 10-100 | Lymphocytes 10-400 |
| CSF glucose | Very low | Normal | Low |
| CSF protein | Very high (> 100) | Mildly elevated | High (100-500) |
| Gram stain | Positive | Negative | Negative (AFB ±) |
| Treatment | IV antibiotics + dexamethasone | Supportive (antiviral for HSV) | HRZE × 2 months + HR × 10 months |
| Prognosis | Serious; 5-10% mortality | Excellent; self-limiting | Serious; risk of disability |
Exam tip for 50 marks: Must include: Introduction + Classification by organism and age + Pathophysiology chain + Classical triad + Age-specific features (infant vs older child) + Meningeal signs (Kernig's + Brudzinski's + nuchal rigidity - draw a diagram if possible) + Petechial rash (meningococcal) + CSF analysis comparison table (biggest marks here) + Emergency management with timing + Antibiotic table (age-based empirical) + Dexamethasone (before antibiotics) + Complications (hearing loss) + Full nursing care plan + Isolation + Prevention. The CSF table and nursing care plan together can account for 25-30 marks.
Next
| Haemoglobin Type | Globin Chains | When Present |
|---|---|---|
| HbA | α₂β₂ | Adult (>95% of adult Hb) |
| HbA₂ | α₂δ₂ | Adult (2-3.5%) |
| HbF (Fetal Hb) | α₂γ₂ | Fetus + neonate; replaced by HbA after birth |
| Hb Bart's | γ₄ | Found in alpha thalassemia (abnormal) |
| HbH | β₄ | Found in HbH disease (abnormal) |
| Type | Genetics | β-chain Production | Clinical Severity |
|---|---|---|---|
| β-Thalassemia Minor (Trait) | Heterozygous (one mutant gene) | Reduced (β+) | Asymptomatic carrier; mild microcytic anaemia |
| β-Thalassemia Intermedia | Compound heterozygous or mild homozygous | Moderately reduced | Moderate anaemia (Hb 7-10 g/dL); variable transfusions |
| β-Thalassemia Major (Cooley's Anaemia) | Homozygous (both genes mutant) | Severely reduced or absent (β⁰) | Severe; transfusion-dependent |
| Genes Deleted | Name | Clinical Features |
|---|---|---|
| 1 gene (-α/αα) | Silent carrier | No symptoms; normal CBC |
| 2 genes (α-/α- or --/αα) | α-Thalassemia Trait | Mild microcytosis; borderline low Hb; no symptoms |
| 3 genes (--/-α) | HbH Disease | Moderate haemolytic anaemia; splenomegaly; intermittent transfusions |
| 4 genes (--/--) | Hb Bart's Hydrops Fetalis | Incompatible with life; severe intrauterine hydrops; stillbirth or neonatal death |
| β (normal) | β^t (mutant) | |
|---|---|---|
| β (normal) | Normal (25%) | Carrier/Trait (25%) |
| β^t (mutant) | Carrier/Trait (25%) | Thalassemia Major (25%) |
| System | Clinical Features |
|---|---|
| General | Pallor (severe), fatigue, weakness, failure to thrive, growth retardation |
| Face | "Thalassaemic facies" - prominent frontal bossing, prominent cheekbones (malar eminences), depressed nasal bridge, protruding upper jaw (maxillary hypertrophy), wide-set eyes; due to marrow expansion |
| Skull X-ray | "Hair-on-end" / "Sun-ray" pattern - radiating bony trabeculae due to marrow expansion |
| Liver | Hepatomegaly (extramedullary haematopoiesis + haemosiderin deposition) |
| Spleen | Massive splenomegaly (one of the largest spleens in clinical medicine); hypersplenism |
| Abdomen | Protuberant due to hepatosplenomegaly |
| Skin | Jaundice (mild), progressive bronze/dark pigmentation (haemosiderosis) |
| Heart | Later: cardiomegaly, heart failure, arrhythmias (from iron overload) |
| Endocrine | Delayed puberty, diabetes mellitus, short stature, hypothyroidism (iron deposition) |
| Bones | Osteoporosis, pathological fractures; premature fusion of epiphyses → short stature |
| Urine | Dark (haemoglobinuria), jaundice causes dark urine |
| Investigation | Findings in β-Thalassemia Major |
|---|---|
| CBC (Complete Blood Count) | Severe anaemia: Hb 2-7 g/dL; microcytic (low MCV), hypochromic (low MCH); elevated reticulocyte count; elevated WBC, reduced platelets (hypersplenism) |
| Peripheral Blood Smear | Microcytes, hypochromic cells, target cells, teardrop cells, fragmented cells (schistocytes), nucleated RBCs (normoblasts), basophilic stippling, Howell-Jolly bodies |
| Haemoglobin Electrophoresis | HbF markedly elevated (> 90% in untransfused), HbA absent or reduced; HbA₂ elevated in trait; confirmatory test |
| Serum Bilirubin | Elevated indirect bilirubin (haemolysis) |
| Serum Iron, Ferritin | Iron: High; Ferritin: Very high (iron overload indicator - normal < 300 ng/mL; target in thalassemia < 1000 ng/mL) |
| TIBC | Low (unlike iron deficiency where TIBC is high) |
| Liver Function Tests | Elevated transaminases (haemosiderosis) |
| Blood glucose | Elevated (iron-induced diabetes) |
| Thyroid function | Low T3, T4 (iron deposition) |
| Echocardiogram | Cardiomegaly, reduced ejection fraction (iron overload) |
| X-ray skull | "Hair-on-end" / "Crew cut" appearance - perpendicular bony trabeculae |
| X-ray long bones | Widened medullary cavity, thin cortex; osteoporosis |
| Abdominal USG | Hepatosplenomegaly; gallstones (chronic haemolysis → pigment stones) |
| MRI Liver/Heart (T2)* | Gold standard for quantifying iron deposition in liver and heart |
| Drug | Route | Dose | Key Points |
|---|---|---|---|
| Desferrioxamine (Deferoxamine/DFO) | SC infusion (8-12 hours overnight); IV | 20-60 mg/kg/day | Gold standard; subcutaneous pump; painful, inconvenient; ophthalmologic and audiological monitoring required |
| Deferiprone (DFP / L1) | Oral | 75-100 mg/kg/day ÷ 3 doses | Oral; good cardiac iron chelation; agranulocytosis (1-2%) - weekly CBC mandatory; arthropathy |
| Deferasirox (DFX/Exjade) | Oral (once daily) | 20-40 mg/kg/day | Most convenient; once daily; renal toxicity; GI side effects; Fanconi syndrome |
| Complication | Management |
|---|---|
| Diabetes mellitus | Insulin therapy; diabetic diet |
| Hypothyroidism | Levothyroxine replacement |
| Hypogonadism/delayed puberty | Sex hormone replacement (testosterone/estrogen) |
| Cardiac iron overload | Intensive chelation (IV DFO continuous); cardiac failure management |
| Osteoporosis | Calcium + Vitamin D; bisphosphonates |
| Hepatitis C infection | Antiviral therapy (direct-acting antivirals) |
| Gallstones | Cholecystectomy if symptomatic |
| Nursing Diagnosis | Related To | Goal |
|---|---|---|
| Activity intolerance | Chronic anaemia | Child participates in age-appropriate activities |
| Imbalanced nutrition: less than body requirements | Increased metabolic needs, poor appetite | Adequate calorie/protein intake; normal growth trajectory |
| Risk for infection | Frequent transfusions, splenectomy, immunosuppression | No infections; early detection |
| Risk for iron overload injury | Repeated transfusions; excess iron absorption | Ferritin < 1000 ng/mL; chelation adherence |
| Impaired body image | Thalassaemic facies, growth retardation, chronic illness | Child verbalizes acceptance; positive self-image |
| Non-compliance r/t chelation | Painful/inconvenient chelation (DFO pump) | Child and family demonstrate compliance with chelation |
| Anxiety/Grief (family) | Chronic, lifelong, inherited disease | Family copes effectively; uses support resources |
| Deficient knowledge | Disease, management, genetic risk | Family demonstrates understanding |
| Feature | β-Thalassemia Trait | Iron Deficiency Anaemia |
|---|---|---|
| MCV | Low | Low |
| MCH | Low | Low |
| Serum Iron | Normal or High | Low |
| Serum Ferritin | Normal or High | Low |
| TIBC | Normal/Low | High |
| HbA₂ | > 3.5% (elevated) | Normal |
| Response to iron therapy | No response | Responds |
| Family history | Positive (may be) | Usually negative |
| Target cells | Present | Rare |
Exam tip for 50 marks: Structure: Introduction + Normal Hb structure + Classification (alpha + beta types clearly tabulated) + Genetics (Punnett square!) + Pathophysiology step-by-step chain + Clinical features of β-thal major with thalassaemic facies + Investigations (Hb electrophoresis is diagnostic) + Management (Blood transfusion protocol + Iron chelation with 3 drugs = most marks) + Splenectomy indications + BMT (curative) + Full nursing care plan + Thalassemia vs IDA comparison + Prevention/genetic counseling. The pathophysiology chain and chelation therapy section carry the most examiner marks.
Next
Old/Damaged RBCs → broken down by Reticuloendothelial System (RES)
↓
Haemoglobin → Haem + Globin
↓
Haem → Biliverdin → UNCONJUGATED BILIRUBIN (UCB)
(Indirect bilirubin - fat-soluble, bound to albumin)
↓
Transported to LIVER (bound to albumin)
↓
Taken up by hepatocytes → conjugated with glucuronic acid
(enzyme: UDP-glucuronyl transferase = UGT1A1)
↓
CONJUGATED BILIRUBIN (Direct bilirubin - water-soluble)
↓
Excreted into bile → intestine → urobilinogen → stercobilin (in stool - makes stool brown)
Some urobilinogen reabsorbed → enterohepatic circulation
| Cause | Mechanism |
|---|---|
| Rh incompatibility | Rh-negative mother, Rh-positive baby; IgG anti-D crosses placenta → haemolysis |
| ABO incompatibility | Mother group O, baby group A or B; naturally occurring IgG anti-A or anti-B causes haemolysis |
| G6PD deficiency | Most common hereditary enzyme deficiency; oxidative stress → haemolysis |
| Hereditary spherocytosis | Abnormal RBC membrane → RBC trapped and destroyed in spleen |
| Sepsis/Infection | Haemolysis + impaired liver function |
| Polycythaemia | High Hct > 65% → more RBC breakdown; seen in SGA babies, twin-twin transfusion |
| Cephalhaematoma | Extravascular blood → reabsorption → increased bilirubin load |
| Swallowed maternal blood | After birth; reabsorbed from gut |
| Cause | Mechanism |
|---|---|
| Physiological | Immature UGT1A1 enzyme |
| Breast milk jaundice | Substances in breast milk inhibit UGT1A1; late-onset (after day 4-7); benign |
| Breastfeeding jaundice | Inadequate breastfeeding → dehydration + increased enterohepatic circulation (early, first 3-5 days) |
| Hypothyroidism | Congenital hypothyroidism delays bilirubin conjugation |
| Crigler-Najjar syndrome | Rare; complete (Type I) or partial (Type II) UGT1A1 deficiency |
| Gilbert syndrome | Mild reduced UGT1A1; benign; usually presents in adolescence |
| Category | Examples |
|---|---|
| Biliary obstruction | Biliary atresia (most important), choledochal cyst |
| Hepatocellular | Neonatal hepatitis (idiopathic or TORCH infections), metabolic liver disease |
| Metabolic | Galactosaemia, tyrosinaemia, alpha-1 antitrypsin deficiency |
| Total Parenteral Nutrition (TPN) | Cholestasis from prolonged TPN |
| Sepsis | Gram-negative sepsis; direct hepatocellular toxicity |
| Kramer Zone | Area Involved | Approximate Bilirubin Level |
|---|---|---|
| Zone 1 | Face, forehead | 5-7 mg/dL |
| Zone 2 | Upper trunk (above umbilicus) | 7-10 mg/dL |
| Zone 3 | Lower trunk + abdomen (to umbilicus) | 10-12 mg/dL |
| Zone 4 | Legs and arms | 12-15 mg/dL |
| Zone 5 | Palms and soles | > 15 mg/dL |
| Investigation | Purpose | Findings |
|---|---|---|
| Total serum bilirubin (TSB) | Diagnosis and monitoring | Elevated; interpret using hour-specific nomogram (Bhutani nomogram) |
| Direct (conjugated) bilirubin | Distinguish unconjugated vs conjugated | < 2 mg/dL (normal); > 2 mg/dL = cholestasis |
| Blood group and Rh type (mother + baby) | Detect ABO/Rh incompatibility | Compare mother and baby blood groups |
| Direct Coombs Test (DCT) | Detect maternal antibodies on baby's RBCs | Positive = HDN |
| CBC + Peripheral smear | Detect haemolysis, polycythaemia | Low Hb, elevated reticulocytes, microspherocytes (ABO), normoblasts |
| Blood culture | Rule out sepsis | Positive in septic jaundice |
| Serum albumin | Binding capacity for bilirubin | Low albumin = higher risk of bilirubin neurotoxicity |
| Thyroid function (T3, T4, TSH) | Rule out hypothyroidism | Low T4, high TSH = hypothyroidism |
| G6PD assay | Detect G6PD deficiency | Reduced enzyme activity |
| Urine and stool colour | Conjugated jaundice assessment | Dark urine + pale/acholic stools = biliary atresia |
| Liver function tests | Hepatocellular disease | Elevated transaminases |
| Abdominal USG | Biliary atresia, choledochal cyst | Absent or hypoplastic gall bladder |
| TcB (Transcutaneous bilirubinometer) | Non-invasive screening | Correlation with TSB; used for initial screening |
| Phase | Clinical Features |
|---|---|
| Phase 1 (Acute - Early) | Poor feeding, lethargy, hypotonia, high-pitched cry, temperature instability |
| Phase 2 (Acute - Intermediate) | Hypertonia → retrocollis (backward arching of neck), opisthotonos (severe backward arching of whole body), irritability, fever, seizures |
| Phase 3 (Acute - Advanced) | Stupor, coma, apnoea, death (70% mortality untreated) |
| Chronic (Survivors) | Cerebral palsy (especially athetoid/dystonic type), high-frequency sensorineural hearing loss, gaze palsy (upward gaze paralysis), dental enamel dysplasia, intellectual disability |
| Type | Description |
|---|---|
| Conventional phototherapy (CPT) | Standard blue fluorescent tubes; baby under tubes |
| Intensive/Double phototherapy | Lights above + fibreoptic mat below; increases light exposure surface area |
| Fibreoptic (biliblanket) | Fibreoptic pad placed under/around baby; can be used with mother |
| LED phototherapy | Light-emitting diode; energy efficient; modern standard |
| Complication | Details |
|---|---|
| Necrotising enterocolitis (NEC) | Most serious; from ischaemia via UVC |
| Air embolism | If not careful during procedure |
| Thromboembolism | Catheter-related clot |
| Electrolyte imbalance | Hypocalcaemia (citrate in blood binds calcium); hyperkalaemia |
| Thrombocytopenia | Dilutional |
| Hypoglycaemia | From donor blood |
| Infection | Sepsis |
| Cardiac arrhythmias | From rapid ion shifts |
| Hypothermia | Cold blood infusion |
| Drug | Mechanism | Use |
|---|---|---|
| Intravenous Immunoglobulin (IVIG) | Blocks Fc receptors on RES macrophages → reduces haemolysis | Used in Rh or ABO HDN; 0.5-1 g/kg over 2-4 hours; reduces need for exchange transfusion |
| Phenobarbitone | Induces UGT1A1 enzyme → increases conjugation | Antenatal (mother) for anticipated jaundice; less commonly used postnatally |
| Feature | Physiological | Pathological |
|---|---|---|
| Onset | After 24 hours | Within 24 hours |
| Duration | Resolves by 10-14 days | May persist > 14-21 days |
| Peak bilirubin | < 12 mg/dL (term) | > 12 mg/dL |
| Rate of rise | < 5 mg/dL/day | > 5 mg/dL/day |
| Direct bilirubin | < 2 mg/dL | May be > 2 mg/dL |
| Cause | Normal neonatal physiology | Underlying disease |
| General condition | Well baby | May be unwell |
| Treatment | Usually none / breastfeeding | Phototherapy / ET |
| Nursing Diagnosis | Related To | Goal |
|---|---|---|
| Risk for injury (kernicterus) | Elevated unconjugated bilirubin | Bilirubin decreases to safe level; no signs of encephalopathy |
| Impaired skin integrity | Phototherapy exposure; rash | Skin remains intact; no burns |
| Risk for injury (eye damage) | Phototherapy lights | Eyes protected; no corneal damage |
| Imbalanced nutrition: less than body requirements | Phototherapy separation; poor breastfeeding | Adequate intake; weight gain resumes |
| Fluid volume deficit | Increased insensible losses under phototherapy | Adequate hydration; urine output ≥ 1-2 ml/kg/hr |
| Anxiety (parents) | Baby in incubator under lights; separation | Parents verbalize understanding; participate in care |
| Deficient knowledge (parents) | Disease process and treatment | Parents demonstrate understanding of jaundice and home monitoring |
| Intervention | Details |
|---|---|
| Anti-D immunoglobulin (Rho-GAM) | Give to ALL Rh-negative mothers at 28-32 weeks gestation (antenatal) |
| Post-delivery Rho-GAM | If baby is Rh-positive, give to mother within 72 hours of delivery |
| Other indications | After any sensitizing event: miscarriage, amniocentesis, CVS, external cephalic version, antepartum hemorrhage |
| Dose | 300 µg IM single dose covers up to 15 ml fetal blood in maternal circulation |
| Effect | Passive immunity destroys fetal Rh-positive RBCs before mother can mount an immune response → prevents sensitization → protects future pregnancies |
Exam tip for 50 marks: Structure: Introduction + Bilirubin metabolism (step-by-step diagram) + Causes (unconjugated vs conjugated clearly separated) + Physiological vs Pathological comparison table (very high marks) + Kramer's zones table + Kernicterus (phases table - 10-15 marks here) + Investigations + Phototherapy management in detail (mechanism + nursing protocol step-by-step = most marks) + Exchange transfusion (indications + complications) + IVIG + Full nursing care plan + Prevention (anti-D immunoglobulin). The phototherapy nursing protocol and kernicterus phases are consistently the highest-scoring parts of this question.
| # | Topic | Key Exam Focus |
|---|---|---|
| 1 | Growth & Development | Milestones table, theories (Erikson/Piaget), DDST |
| 2 | National Immunization Schedule | NIS table, cold chain equipment, AEFI |
| 3 | Preterm/LBW Baby | Thermoregulation, KMC, NRP, complications |
| 4 | IMNCI | Danger signs, colour-coded classification, ORS plans |
| 5 | PEM (Kwashiorkor & Marasmus) | Comparison table, WHO 10 steps, chelation |
| 6 | Nephrotic Syndrome | Pathophysiology chain, steroid protocol, nursing care |
| 7 | Tetralogy of Fallot | 4 defects, tet spell management, surgical repair |
| 8 | Meningitis | CSF table, antibiotics, dexamethasone, nursing care |
| 9 | Thalassemia | Blood transfusion, iron chelation, BMT, genetics |
| 10 | Neonatal Jaundice | Phototherapy protocol, kernicterus phases, exchange transfusion |
Next
All 10 top topics are done! What would you like to do next?